Organisation paid for research Program year 2023 Source: CMS Open Payments

Viable Research Management DBA Alas Science

Neither a doctor nor a teaching hospital

Research payments

$152,300

12 payments

Through program year 2023, Viable Research Management DBA Alas Science is reported as receiving $152,300 in research payments, across 12 payments.

By program year

3 rows
Year Kind Amount Payments
2023 Research $32,680 3
2022 Research $78,620 8
2021 Research $41,000 1

Breakdown

Who paid Research payments · program years 2021–2023
  1. Teva Pharmaceuticals USA, Inc. $152,300 12 payments
Studies the money was for Research payments · program years 2021–2023
  1. A Randomized, Double-Blind, Multinational, Multicenter Study to Compare Efficacy, Safety, and Immunogenicity of TVB-009P and Denosumab (Prolia) in Patients With Postmenopausal Osteoporosis $152,300 12 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.

Provenance

Source: CMS Open Payments · through program year 2023

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record